Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL
by Arseni, Lavinia (Author)
, Sigismondo, Gianluca (Author)
, Yazdanparast, Haniyeh (Author)
, Hermansen, Johanne U. (Author)
, Mack, Norman (Author)
, Ohl, Sibylle (Author)
, Kalter, Verena (Author)
, ̇Iskar, Murat (Author)
, Kalxdorf, Mathias (Author)
, Friedel, Dennis (Author)
, Rettel, Mandy (Author)
, Paul, Yashna (Author)
, Ringshausen, Ingo (Author)
, Eldering, Eric (Author)
, Dubois, Julie (Author)
, Kater, Arnon P. (Author)
, Zapatka, Marc (Author)
, Rößner, Philipp M. (Author)
, Tausch, Eugen (Author)
, Stilgenbauer, Stephan (Author)
, Dietrich, Sascha (Author)
, Savitski, Mikhail M. (Author)
, Skånland, Sigrid S. (Author)
, Krijgsveld, Jeroen (Author)
, Lichter, Peter (Author)
, Seiffert, Martina (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource